首页 | 本学科首页   官方微博 | 高级检索  
     

食管癌术后纵隔转移灶同时加量调强放射治疗分析
引用本文:于长华,朱振亚,韩济华,朱卫国,潘鹏,李涛. 食管癌术后纵隔转移灶同时加量调强放射治疗分析[J]. 陕西肿瘤医学, 2010, 18(3): 501-503
作者姓名:于长华  朱振亚  韩济华  朱卫国  潘鹏  李涛
作者单位:江苏省淮安市第一人民医院南京医科大学附属淮安医院肿瘤放疗科,江苏淮安223300
基金项目:江苏省淮安市科技支撑项目(HAS08005)
摘    要:目的:探讨食管癌根治术后纵隔转移灶同时加量调强放疗的意义和效果。方法:39例食管癌根治术后发生纵隔转移患者,设定原发灶和预防照射区进行SIB—IMRT(simultaneous integrated boost intensity-modulated radiation therapy)计划设计。定义2个靶区:P1rvl为需要加量照射的淋巴结靶区,给予69Gy(2.3×30次);PTV2为预防照射区,给予54Gy(1.8×30次)的剂量,设计等角度5野调强计划。结果:5野调强获得了满意的剂量分布,患者可在6周内完成治疗计划,所有患者完成了放疗,治疗后3个月复查CT,病灶达CR(complete response)占66.7%(36/54),Pit(partial response)占33.3%(18/54),总有效率(CR+PR)达到100.0%。结论:食管癌根治术后纵隔转移患者进行同时加量调强放射治疗物理学优势明显,可以明显提高局部控制率,急性放射治疗反应可耐受,具有良好的应用前景。

关 键 词:食管肿瘤  纵隔转移  调强放射治疗  同步加量照射

Simultaneous integrated boost intensity- modulated radiation therapy for mediastinum metastasis in patients with esophageal carcinoma after operation
YU Chang - hua,ZHU Zhen - ya,HAN Ji - hua,ZHU Wei - guo,PAN Peng,LI Tao. Simultaneous integrated boost intensity- modulated radiation therapy for mediastinum metastasis in patients with esophageal carcinoma after operation[J]. Shaanxi Oncology Medicine, 2010, 18(3): 501-503
Authors:YU Chang - hua  ZHU Zhen - ya  HAN Ji - hua  ZHU Wei - guo  PAN Peng  LI Tao
Affiliation:(Department of Radiation Oncology,Huai'an First People Hospital, Huai'an 223300, China.)
Abstract:Objective :To investigate the clinical efficacy and significance of simultaneous integrated boost intensity -modulated radiotherapy (SIB -IMRT) for the patients with esophageal carcinoma after the radical esophagectomy and with mediastinal metastasis. Methods: SIB - IMRT plans were designed for 39 patients with esophageal carcinoma after the radical esophagectomy and with mediastinal metastasis. Two target volumes were predefined: PTV1, the target volume of the lymph node region,which was given to 69Gy(2.3Gy fractions), and PTV2, the target volume of elec- tively treated region ,which was given to 54Gy( 1.8Gy fractions). Five equispaced coplanar beams were applied. Re- suits:The plan with 5 intensity - modulated beams could produce good dose distribution for the two target volumes. All the patients completed the treatments in 6 weeks. The outcome was evaluated 3 months after SIB - IMRT. Patients had CR in 66.7% (36/54) ;PR 33.3% (18/54). The overall response rate was 100.0%. Conclusion: SIB - IMRT can reach a higher value of some radiation physical parameters for the patients with esophageal carcinoma after the radical esophagectomy and with mediastinal metastasis. Local - regional control rate was improved by using SIB - IMRT. The acute radiation toxicity of SIB - IMRT was well tolerated. SIB - IMRT is a promising radiotherapy modality for the advanced esophageal carcinoma.
Keywords:esophageal neoplasms  mediastinurn metastasis  intensity - modulated radiation therapy  simultaneous integrated boost radiation therapy
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号